RxDoctor Payments Data

Melissa Herring, DO

Family Medicine · Perkins, OKNPI 1124447792

Payments from drug & device makers

$534in general payments, 2019–2025

Across 33 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$174
  • AbbVie$134
  • Amgen$40
  • GSK$32
  • Amarin Pharma, Inc.$26
  • Astellas Pharma US Inc$23
  • plus $105 from 7 others

What the payments were for

  • Food & beverage$534100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$534 in reported general payments places this provider in the 55th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$112,492
Medicare patients
285
Services billed
2,019

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide31$47,315
JanuviaSitagliptin Phosphate49$47,152
EliquisApixaban33$35,441
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$32,477
OzempicSemaglutide22$21,377
TrulicityDulaglutide17$19,267
JardianceEmpagliflozin25$14,366
XareltoRivaroxaban21$12,985
FarxigaDapagliflozin Propanediol18$10,812
GemtesaVibegron18$10,363
Breo ElliptaFluticasone/Vilanterol15$7,462
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$5,020
Epinephrine15$4,911
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$4,510
Atorvastatin Calcium349$3,629

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$174$66,58148 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$32$43,02671 claims
Boehringer IngelheimJardiance$14$14,36625 claims
AstraZenecaFarxiga$14$10,81218 claims
AbbVieSynthroid$134$1,73121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Perkins

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →